The December 2025 edition of the 1Cell.Ai Newsletter reflects on a year that brought major changes in precision oncology and how cancer care is becoming more connected, data-driven, and patient-focused. From advances in liquid biopsy and AI-assisted decision making to the growing role of multi-omics testing, this issue gives readers a simple and practical look at where oncology is heading next.
One of the key highlights is the opening of 1Cell.ai’s new globally accredited Precision Diagnostics Laboratory in Pune, designed to deliver high-quality molecular testing with faster turnaround times and strong quality standards. The newsletter also introduces OncoIndx® TBx, a new integrated genomic and transcriptomic profiling solution aimed at helping doctors uncover deeper treatment insights in difficult cancer cases.
This edition also features a real clinical case showing how combined tissue, liquid biopsy, and RNA analysis helped identify important treatment options in advanced lung cancer that may have otherwise been missed.
Download and read this edition to get a simple and meaningful overview of how science, technology, and patient care are coming together to shape the future of oncology.